# A Study of People With CD30 Positive Lymphoma in China

> **NCT05506774** · — · COMPLETED · sponsor: **Takeda** · enrollment: 1006 (actual)

## Conditions studied

- Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05506774
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-28
- **Primary completion:** 2024-07-03
- **Final completion:** 2024-07-03
- **Target enrollment:** 1006 (ACTUAL)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05506774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05506774, "A Study of People With CD30 Positive Lymphoma in China". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05506774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*